UNC Exercise and Sport Science
Chapel Hill, North Carolina, 27599, United States
NCT Number: NCT01745016
Beta-alanine, as a method to increase muscle carnosine, has been shown to enhance muscle buffering capacity and delay fatigue. Various fatigue tests have been utilized to examine the effectiveness of beta-alanine supplementation. The physical working capacity test has been used to show significant increases in physical working capacities following supplementation. The physical working capacity tests were originally developed by Moritani et al. 1981 and Devries et al. 1982 to measure the point of onset of muscular fatigue. It is hypothesized that beta-alanine will increase physical working capacity at heart rate threshold, thereby signifying a delay in fatigue.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Chapel Hill, North Carolina, 27599, United States
An equal number of men and women will be recruited [Men, n=20 (10 placebo [PL]; 10 beta-alanine (Active)]; [Women,n=20 (10 PL; 10 Active)]. Men and women will be randomly assigned to respective groups to allow for equal numbers in supplement and placebo groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 0 to 4 weeks
University of North Carolina, Chapel Hill
Other
The Effect of 28 Days of Beta-alanine Supplementation on the Physical Working Capacity at Heart Rate Threshold (PWCHRT)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01294332
Behavior, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06840873
Behavior, COVID-19
Tiapei, Taiwan
View Trial DetailsNCT07105410
Behavior, Bites and Stings
Lisbon, Portugal
View Trial DetailsNCT05877339
Behavior, Exercise
Istanbul, Turkey (Türkiye)
View Trial Details